Huub C Gelderblom

Summary

Affiliation: Academic Medical Center
Country: The Netherlands

Publications

  1. ncbi High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection
    Tim C M A Schreuder
    Department of Gastroenterology and Hepatology, AMC Liver Centre, University of Amsterdam, Amsterdam, The Netherlands
    Liver Int 28:39-46. 2008
  2. ncbi Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum
    Huub C r Gelderblom
    Section of Clinical Virology, Department of Medical Microbiology, Academic Medical Centre, University of Amsterdam, The Netherlands
    Antivir Ther 11:95-103. 2006
  3. ncbi Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure
    Huub C Gelderblom
    Section of Clinical Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Antivir Ther 12:423-7. 2007
  4. ncbi Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile
    Huub C Gelderblom
    Department of Gastroenterology and Hepatology, AMC Liver Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Liver Int 27:944-53. 2007
  5. ncbi Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy
    Huub C Gelderblom
    AMC Liver Center, Department of Gastroenterology and Hepatology
    Scand J Gastroenterol 43:857-69. 2008
  6. ncbi Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a
    Huub C Gelderblom
    Department of Gastroenterology and Hepatology, AMC Liver Center, Homburg Saar, Germany
    Scand J Gastroenterol 43:1122-7. 2008
  7. ncbi Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection
    Eleanor Barnes
    AMC Liver Center, Department of Gastroenterology and Hepatology, University of Amsterdam, Amsterdam, The Netherlands
    J Infect Dis 199:819-28. 2009

Detail Information

Publications7

  1. ncbi High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection
    Tim C M A Schreuder
    Department of Gastroenterology and Hepatology, AMC Liver Centre, University of Amsterdam, Amsterdam, The Netherlands
    Liver Int 28:39-46. 2008
    ..We prospectively screened for DM during and after IFN-alpha therapy for chronic HCV infection...
  2. ncbi Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum
    Huub C r Gelderblom
    Section of Clinical Virology, Department of Medical Microbiology, Academic Medical Centre, University of Amsterdam, The Netherlands
    Antivir Ther 11:95-103. 2006
    ..This is clinically relevant because underestimation of HCV RNA levels during therapy may lead physicians into making incorrect treatment decisions...
  3. ncbi Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure
    Huub C Gelderblom
    Section of Clinical Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Antivir Ther 12:423-7. 2007
    ..We studied this phenomenon in subsets of patients...
  4. ncbi Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile
    Huub C Gelderblom
    Department of Gastroenterology and Hepatology, AMC Liver Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Liver Int 27:944-53. 2007
    ..Therefore, we studied the presence of HCV RNA in monocytes and monocyte-derived DCs from chronic HCV patients...
  5. ncbi Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy
    Huub C Gelderblom
    AMC Liver Center, Department of Gastroenterology and Hepatology
    Scand J Gastroenterol 43:857-69. 2008
    ....
  6. ncbi Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a
    Huub C Gelderblom
    Department of Gastroenterology and Hepatology, AMC Liver Center, Homburg Saar, Germany
    Scand J Gastroenterol 43:1122-7. 2008
    ..4A protease inhibitor telaprevir (VX-950), with or without peginterferon alfa-2a (Peg-IFN)...
  7. ncbi Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection
    Eleanor Barnes
    AMC Liver Center, Department of Gastroenterology and Hepatology, University of Amsterdam, Amsterdam, The Netherlands
    J Infect Dis 199:819-28. 2009
    ..The effect that high-dose interferon (IFN)-alpha induction therapy for hepatitis C virus (HCV) infection has on cellular immune responses is currently unknown...